We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
-$3.89M
Cap. Flow
+$11.2M
Cap. Flow %
6.35%
Top 10 Hldgs %
22.1%
Holding
256
New
24
Increased
39
Reduced
133
Closed
21

Top Buys

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$3.86M
2
RVNC
Revance Therapeutics, Inc.
RVNC
+$3.65M
3
TSVT
2seventy bio
TSVT
+$3.13M
4
QURE icon
uniQure
QURE
+$3.1M
5
EMBC icon
Embecta
EMBC
+$2.13M

Top Sells

Rank Stock Value
1
AHCO icon
AdaptHealth
AHCO
+$3.44M
2
ELAN icon
Elanco Animal Health
ELAN
+$2.97M
3
CNC icon
Centene
CNC
+$2.7M
4
MBB icon
iShares MBS ETF
MBB
+$2.05M
5
LNTH icon
Lantheus
LNTH
+$1.93M

Sector Composition

Rank Sector Weight
1 Healthcare 61.71%
2 Real Estate 10.29%
3 Financials 3.55%
4 Technology 3.29%
5 Energy 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VKTX icon
76
Viking Therapeutics
VKTX
$4.31B
$664K 0.38%
+60,000
New +$858K
IRTC icon
77
iRhythm Holdings
IRTC
$3.64B
$660K 0.37%
+7,000
New +$712K
EXEL icon
78
Exelixis
EXEL
$14.1B
$656K 0.37%
30,000
-3,000
-9% -$62.8K
GILD icon
79
Gilead Sciences
GILD
$167B
$637K 0.36%
8,500
– –
ZBRA icon
80
Zebra Technologies
ZBRA
$12.7B
$591K 0.34%
+2,500
New +$679K
BBJP icon
81
JPMorgan BetaBuilders Japan ETF
BBJP
$17.1B
$551K 0.31%
10,975
-414
-4% -$21.3K
NUVB icon
82
Nuvation Bio
NUVB
$2.02B
$549K 0.31%
410,000
+65,000
+19% +$108K
NNDM
83
Nano Dimension
NNDM
$326M
$544K 0.31%
200,000
-50,000
-20% -$145K
GMED icon
84
Globus Medical
GMED
$10.5B
$497K 0.28%
+10,000
New +$559K
VTRS icon
85
Viatris
VTRS
$20.1B
$468K 0.27%
47,500
-7,500
-14% -$78.1K
PNT
86
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$450K 0.26%
67,400
-2,600
-4% -$21.6K
CI icon
87
Cigna
CI
$74.5B
$435K 0.25%
1,519
-112
-7% -$31.9K
CAH icon
88
Cardinal Health
CAH
$53.5B
$420K 0.24%
4,835
-382
-7% -$34.5K
VTYX
89
DELISTED
Ventyx Biosciences
VTYX
$417K 0.24%
+12,000
New +$415K
NOTE
90
DELISTED
FiscalNote
NOTE
$416K 0.24%
16,667
– –
CLDX icon
91
Celldex Therapeutics
CLDX
$2.77B
$413K 0.23%
15,000
– –
ROIV icon
92
Roivant Sciences
ROIV
$24.8B
$409K 0.23%
+35,000
New +$396K
AKRO
93
DELISTED
Akero Therapeutics
AKRO
$405K 0.23%
+8,000
New +$372K
BKLN icon
94
Invesco Senior Loan ETF
BKLN
$7.19B
$404K 0.23%
19,258
-228
-1% -$4.8K
SOUN icon
95
SoundHound AI
SOUN
$2.73B
$402K 0.23%
200,000
– –
EMHY icon
96
iShares JPMorgan EM High Yield Bond ETF
EMHY
$613M
$398K 0.23%
11,696
-168
-1% -$5.85K
MCK icon
97
McKesson
MCK
$98.5B
$397K 0.23%
913
-52
-5% -$21.9K
CWB icon
98
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.78B
$396K 0.22%
5,834
-180
-3% -$12.5K
PBP icon
99
Invesco S&P 500 BuyWrite ETF
PBP
$348M
$393K 0.22%
18,437
-101
-0.5% -$2.22K
DWX icon
100
State Street SPDR S&P International Dividend ETF
DWX
$525M
$389K 0.22%
11,824
+42
+0.4% +$1.44K
2 3
4
5 6

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, AlphaCentric Advisors held 256 positions worth $176M, down 2.2% from $180M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors deployed $11.2M of net new capital in Q3 2023, opening 24 new positions and adding to 39 existing holdings. Its largest new stake was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $1.9M trimmed.

  • AlphaCentric Advisors's largest Q3 2023 buy was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.
  • AlphaCentric Advisors added most to Walgreens Boots Alliance in Q3 2023, an estimated $3.86M increase.
  • AlphaCentric Advisors's biggest Q3 2023 reduction was Jazz Pharmaceuticals, cutting an estimated $1.9M.
  • AlphaCentric Advisors fully exited AdaptHealth in Q3 2023, selling an estimated $3.44M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $176M portfolio in Q3 2023.
  • AlphaCentric Advisors opened 24 new positions and closed 21 in Q3 2023.
  • AlphaCentric Advisors's portfolio value fell 2.2% quarter-over-quarter to $176M.

Based on AlphaCentric Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.